The new intraday mechanism enables rapid, potentially frequent share issuance without prior shareholder approval, increasing dilution risk. Traders should monitor for sudden drawdowns, especially given the lack of disclosed issuance cap. The $22,000 fee suggests minimal immediate capital benefit, reinforcing concerns about financing structure.
Price Chart
Executive Summary
Psyence Biomedical Ltd. amended its existing stock purchase agreement with White Lion Capital to introduce a new 'Intraday Purchase Notice' mechanism, allowing the company to sell up to 5% of its average daily trading volume per notice at a price based on the lowest traded price during a one-hour valuation period. The amendment also includes a $22,000 payment from White Lion to the company for document preparation.
Key Facts
- Amendment No. 3 adds an 'Intraday Purchase Notice' mechanism to the existing Common Stock Purchase Agreement with White Lion Capital.
- The company may now require White Lion to purchase up to 5% of the Average Daily Trading Volume per intraday notice.
- Purchase price is set at the lowest traded price during a one-hour period after acceptance, subject to a floor price.
- White Lion must consent within 15 minutes of notice delivery; otherwise, the notice is void.
- White Lion will pay the company a $22,000 legal document preparation fee within two business days.
- The amendment does not disclose any cap on total issuance or total funding potential under the agreement.
Financial Impact
Up to 5% of average daily trading volume per intraday drawdown, with no disclosed aggregate limit. The $22,000 fee is a one-time payment.
Risk Factors
- Significant shareholder dilution due to uncapped and accelerated issuance rights.
- Potential for downward price pressure as shares can be sold at the lowest intraday price, incentivizing investor selling ahead of purchases.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-045373 |
| Document: ea0286941-6k_psyence.htm | 0001213900-26-045373 |
| Document: 0001213900-26-045373-index-headers.html | 0001213900-26-045373 |
| Document: 0001213900-26-045373-index.html | 0001213900-26-045373 |
| Document: 0001213900-26-045373.txt | 0001213900-26-045373 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 5, 2026 20w ago | 6-K | $0.0500 $0.0236 | ▼ −52.80% | ▼ −55.85% | — |
Apr 23, 2026 26w ago | 6-K | $0.0200 $0.0301 | ▲ +50.50% | ▲ +45.42% | — |
Apr 20, 2026 27w ago | 6-K | $0.0200 $0.0200 | · 0.00% | ▲ +6.78% | — |
Apr 17, 2026 27w ago | 6-K | $0.0200 $0.0200 | · 0.00% | ▼ −6.78% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers